Literature DB >> 13883499

A comparative evaluation of adrenalectomy and cortisone in the treatment of advanced mammary carcinoma.

T L DAO, E TAN, V BROOKS.   

Abstract

Entities:  

Keywords:  ADRENALECTOMY; BREAST NEOPLASMS/therapy; CORTISONE/therapy

Mesh:

Substances:

Year:  1961        PMID: 13883499     DOI: 10.1002/1097-0142(196111/12)14:6<1259::aid-cncr2820140616>3.0.co;2-4

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  8 in total

1.  Corticosteroids in Therapy of Advanced Mammary Cancer.

Authors:  B A Stoll
Journal:  Br Med J       Date:  1963-07-27

Review 2.  Current status of the management of patients with endocrine-sensitive tumors. I. Introduction and carcinoma of the breast.

Authors:  L G Crowley
Journal:  Calif Med       Date:  1969-01

3.  Cancer of the breast. Treatment of the advanced disease.

Authors:  J Hayward
Journal:  Br Med J       Date:  1970-05-23

4.  Comparison of different endocrine therapies in management of bone metastases from breast carcinoma.

Authors:  I E Smith; V Macaulay
Journal:  J R Soc Med       Date:  1985       Impact factor: 5.344

5.  Medical adrenalectomy with aminoglutethimide: clinical studies in postmenopausal patients with metastatic breast carcinoma.

Authors:  S A Wells; R J Santen; A Lipton; D E Haagensen; E J Ruby; H Harvey; W G Dilley
Journal:  Ann Surg       Date:  1978-05       Impact factor: 12.969

6.  Hormonal treatment of disseminated cancer of the female breast.

Authors:  G S GORDAN; W P GRAHAM; L GOLDMAN; R PAPAC; G E SHELINE; J VAETH; J WITT
Journal:  Calif Med       Date:  1963-04

Review 7.  Treatment of breast cancer with aromatase inhibitors--current status and future prospects.

Authors:  P E Lønning; M Dowsett; T J Powles
Journal:  Br J Cancer       Date:  1989-07       Impact factor: 7.640

Review 8.  Systematic review of the clinical effect of glucocorticoids on nonhematologic malignancy.

Authors:  Bruce D Keith
Journal:  BMC Cancer       Date:  2008-03-28       Impact factor: 4.430

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.